$3.44
Price
$1.0B
Market Cap
—
P/E Ratio
-4.5
Forward P/E
$-0.49
EPS (TTM)
—
Dividend Yield
$534M
Cash
$143M
Total Debt
303M
Shares Out
$1.94
$6.51
52-Week Range
Institutional Ownership of ABCELLERA BIOLOGICS INC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for ABCELLERA BIOLOGICS INC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2025-Q3 | |||||
| BUY | NEW | 269.2K | $1M | $4.35 | |
| 2021-Q2 | |||||
| SELL | EXIT | — | — | $28.25 | |
| 2021-Q1 | |||||
| SELL | -1.0% | 19.1M | $648M | $39.70 | |
| 2020-Q4 | |||||
| BUY | NEW | 19.3M | $776M | $46.99 | |
Insider Trading for ABCELLERA BIOLOGICS INC
6 Months Insider Sentiment
Buy $178K
Sell $0
1
Buys
0
Sells
+178K
Net
1
Grants
Largest
$178K
Montalbano
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Dec 18, 2025 | Thermopylae Holdings Ltd. | 10% Owner | GRANT | 225.0K | — | — |
| Nov 26, 2025 | John S. Montalbano | Director | BUY | 50.0K | $3.57 | $178K |